Skip to main contentSkip to navigation
Sirius Investors
Shionogi & Co., Ltd.

Shionogi & Co., Ltd.

SGIOY
OTCHealthcare

Shionogi & Co., Ltd. (SGIOY) Investment Research Dashboard

About Shionogi & Co., Ltd. (SGIOY) stock analysis

Get live SGIOY stock price $8.84, comprehensive Shionogi & Co., Ltd. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time SGIOY stock data and investment insights.

8.84
0.68%Today
Market Cap
15.05B
Volume
2.91K
52W High
12.00
52W Low
7.65

Loading chart data...

Shionogi & Co., Ltd. (SGIOY) Overview

Shionogi & Co., Ltd. (SGIOY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, SGIOY trades at $8.84 with a market capitalization of 15.05B . Over the past 52 weeks, SGIOY has traded between $7.65 and $12.00 , with the current price positioned at approximately 27% of this range . ...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 15.05B
  • Current price: $8.84
  • 52-week range: $7.65 - $12.00
  • P/E ratio: 11.05

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Shionogi & Co., Ltd. operates as a Japanese pharmaceutical enterprise, dedicated to the discovery, creation, manufacturing, and commercialization of a diverse array of medicines, diagnostic reagents, and medical equipment within Japan. The firm marke...

Company Information

CEO
Isao Teshirogi
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6223

Contact Information

Address
1-8, Doshomachi 3-chome
Country
JP

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 11.1)

Lower volatility stock (Beta: 0.04) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Shionogi & Co., Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Shionogi & Co., Ltd.
  • Investors should consider how Shionogi & Co., Ltd. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

15.05B

P/E Ratio (TTM)

11.05

Beta

0.04

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

80/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+5.7%+6.1%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%+3.3%+3.5%24.1
80/100⭐⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
56/100⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
56/100⭐⭐⭐⭐
Real Estate-0.5%-0.1%-1.6%29.2
43/100⭐⭐⭐
Energy-2.1%-5.8%-5.1%19.1
39/100⭐⭐
Utilities-1.0%-3.0%-5.9%26.8
28/100⭐⭐
Industrials+0.6%+1.7%-11.2%30.1
26/100⭐⭐
Consumer Cyclical+0.5%-0.4%-6.3%43.0
21/100
Technology+0.6%-2.3%-9.6%40.7
17/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.